#postcovid19condition
LightNews LightNews
spoonieresources.bsky.social
Is long-COVID actually a thing of the past?
The evidence says "no"...

This video by PacoOnPause gives you the brief overview (but there's more in the thread below):
x.com/PacoOnPause/...
#longCOVID #PostCOVID19Condition

⬇️ more ⬇️
PACO on X: "A lot of you are risking your health because of a comforting lie.. https://t.co/M65QyNK2pL" / X
A lot of you are risking your health because of a comforting lie.. https://t.co/M65QyNK2pL
x.com
May 31, 2026 at 11:29 AM
tomkindlon.bsky.social
"we observed sustained negative impacts of PCC on health outcomes 2.5 years after initial COVID-19 in non-hospitalised individuals, despite minor improvements over time."

link.springer.com/article/10.1...

Screenshot from latest Science for ME weekly update

#LongCovid #postCOVID19condition
Long-term health outcomes and risk factors for low self-rated health in non-hospitalised adults with post-COVID-19 condition: a 2.5-year cohort study — Törnberg et al. "we observed sustained negative impacts of PCC on health outcomes 2.5 years after initial COVID-19 in non-hospitalised individuals, despite minor improvements over time."
February 12, 2026 at 2:08 AM
ularkin.bsky.social
So #Ireland won the #rugby Triple Crown🇫🇷

#Canada won #hockey 4 Nations 🇨🇦

Life is not all about #MS

But this #longcovid really sucks

Who here can talk about #longcovid exacerbating #ms,
#postcovid19condition and testing options and services available in #Canada #novascotia
Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis - PubMed
The study has been registered at ClinicalTrials.gov (study registration number: NCT05403463).
pubmed.ncbi.nlm.nih.gov
February 24, 2025 at 5:08 AM
sczoomers.bsky.social
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19

The complexity and dynamics of the autoantibody repertoire emerging with COVID-19.

#auotantibodies #postCOVID19condition

www.nature.com/articles/s41...
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19 - Nature Communications
Autoantibody immune responses could contribute to acute and post-COVID-19 symptoms. Here, the authors describe longitudinal autoantibody responses in a cohort of healthcare workers and hospitalised CO...
www.nature.com
October 19, 2024 at 11:28 PM